WestJet receives shareholder approval for acquisition by Onex

By gor goz
Share

Canadian airline WestJet’s acquisition by Toronto based investment fund Onex Corporation has been approved by shareholders.

With 60% of voting shares and 54% of stock options represented at the meeting, over 92.5% of those voting were in favor of the deal.

Ed Sims, WestJet's President and Chief Executive Officer, said, "We are very pleased to obtain overwhelming support from our securityholders at today's special meeting. Receiving this support is an important step on our path to closing the transaction, and we continue to engage with the necessary authorities on the remaining approvals."

SEE ALSO:

The deal, once completed, will see WestJet acquired for CA$31 per share, meaning the transaction will come in at roughly CA$5bn (US$3.71bn).

The news comes after the June approval of the deal from Canadian Minister of Transport Marc Garneau on the basis that the acquisition does not raise public interest issues related to national transportation. Other conditions still need to be satisfied before closing, including regulatory and court approval. The company expects the transaction to go through in the latter part of 2019 or early 2020.

WestJet trades on the Toronto Stock Exchange under the symbol “WJA”, as does Onex as “ONEX”.

Share

Featured Articles

What is Nestlé CEO Laurent Freixe’s Action Plan?

Newly appointed CEO sets out action plan involving separating water brands into standalone business and boosting advertising and marketing spend

Will Mulberry Turn a New Leaf Under CEO Andrea Baldo?

International British luxury brand cuts quarter of head office staff as newly appointed CEO conducts strategic review

Female Board Members of Biggest UK Companies Paid 69% Less

Female board members of FTSE 100 companies are paid 69% less than male counterparts, as they find themselves frozen out of the biggest roles

Is This the Next CEO of LVMH?

Leadership & Strategy

How Burberry’s New CEO Is Going Back to Basics

Leadership & Strategy

Is Bayer CEO Bill Anderson Running Out of Time?

Leadership & Strategy